Comments on an animal model of depression;À propos d'un modèle animal de la dépression

Annales Pharmaceutiques Francaises

Volumn 62, Issue 5, 2004, Pages 332-342

  Vaugeois, J M ^a   El Yacoubi, M ^a   Costentin, J ^a  

^a UNIVERSITÉ DE ROUEN   (France)

Author keywords

Animal model; Antidepressant; Depression; Serotonin; Sleep

Indexed keywords

ANTIDEPRESSANT AGENT; AUTORECEPTOR; CORTICOSTERONE; FLUOXETINE; SEROTONIN; SEROTONIN 1A RECEPTOR; SUCROSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; DRUG SCREENING; EXPERIMENTAL TEST; FEMALE; FORCED SWIMMING TEST; GENETIC SUSCEPTIBILITY; HIPPOCAMPUS; HYPOTHERMIA; MALE; MOUSE; NEUROCHEMISTRY; NEUROPHYSIOLOGY; NONHUMAN; PATHOPHYSIOLOGY; RAPHE NUCLEUS; RECEPTOR UPREGULATION; REM SLEEP; SEROTONIN METABOLISM; SEROTONINERGIC NERVE CELL; SEROTONINERGIC SYSTEM; SLEEP WAKING CYCLE; STRESS; TAIL SUSPENSION TEST; TREATMENT OUTCOME; ANIMAL; BRAIN LEVEL; DISEASE MODEL; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; REVIEW;

ANIMALS; BRAIN CHEMISTRY; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; FEMALE; MALE; MICE; RECEPTOR, SEROTONIN, 5-HT1A;

EID: 4644309106     PISSN: 00034509     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0003-4509(04)94322-2     Document Type: Article

References (39)

1. Rouillon F. Séméiologie in Les troubles dépressifs. Montrouge: John Libbey Eurotext 1997; 31-40.
2. Tassin JP. Interrelations entre les neuromédiateurs impliqués dans la dépression et les antidépresseurs. Encéphale 1994; 20 (Spec No 4): 623-8.
3. Olivier B, van der Heyden J. New developments in antidepressant research in Depression: neurobiological, psychopathological and therapeutic advances. New York: John Wiley 1997: 445-57.
4. Gorwood P, Rouillon F. Épidémiologie des maladies mentales. Encycl Méd Chir (Elsevier Paris), Psychiatrie 1996; 37-878-A-10: 10 p.
5. Kendler KS, Walters EE, Truett KR, Heath AC, Neale MC, Martin NG, Eaves LJ. Sources of individual differences in depressive symptoms: analysis of two samples of twins and their families. Am J Psychiatry 1994; 151: 1605-14.
6. Rifkin L, Gurling H. Genetic aspects of affective disorders in Biological aspects of affective disorders. Londres: Academic Press 1991: 305-35.
7. Jenaway A, Paykel ES. Life events and Depression. in Depression: neurobiological, psychopathological and therapeutic advances. New York: John Wiley 1997: 279-95.
8. Anisman H, Zacharko RM. Multiple neurochemical and behavioral consequences of stressors: implications for depression. Pharmacol Ther 1990; 46: 119-36.
9. Steru L, Chermat R, Thierry B, Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 1985; 85: 367-70.
10. Vaugeois J-M, Passera G, Zuccaro F, Costentin J. Individual differences in response to imipramine in the mouse tail suspension test. Psychopharmacology (Berl) 1997; 134: 387-91.
11. van der Heyden JA, Molewijk E, Olivier B. Strain differences in response to drugs in the tail suspension test for antidepressant activity. Psychopharmacology (Berl) 1987; 92: 127-30.
12. Trullas R, Jackson B, Skolnick P. Genetic differences in a tail suspension test for evaluating antidepressant activity. Psychopharmacology (Berl) 1989; 99: 287-8.
13. Liu X, Gershenfeld HK. Genetic differences in the tail-suspension test and its relationship to imipramine response among 11 inbred strains of mice. Biol Psychiatry 2001; 49: 575-81.
14. Liu X, Gershenfeld HK. An exploratory factor analysis of the Tail Suspension Test in 12 inbred strains of mice and an F2 intercross. Brain Res Bull 2003; 60: 223-31.
15. Vaugeois J-M, Odièvre C, Loisel L, Costentin J. A genetic mouse model of helplessness sensitive to imipramine. Eur J Pharmacol 1996; 316: R1-R2.
16. El Yacoubi M, Bouali S, Popa D, Naudon L, Leroux-Nicollet I, Hamon M, Costentin J, Adrien J, Vaugeois J-M. Behavioral, neurochemical, and electrophysiological characterization of a genetic mouse model of depression. Proc Natl Acad Sci USA 2003; 100: 6227-32.
17. Steru L, Chermat R, Thierry B, Mico JA, Lenegre A, Steru M, Simon P, Porsolt RD. The automated Tail Suspension Test: a computerized device which differentiates psychotropic drugs. Prog Neuropsychopharmacol Biol Psychiatry 1987; 11: 659-71.
18. Kupfer DJ. REM latency: a psychobiologic marker for primary depressive disease. Biol Psychiatry 1976; 11: 159-74.
19. Arborelius L, Owens MJ, Plotsky PM, Nemeroff CB. The role of corticotropin-releasing factor in depression and anxiety disorders. J Endocrinol 1999; 160: 1-12.
20. Hirschfeld RM. History and evolution of the monoamine hypothesis of depression. J Clin Psychiatry 2000; 61 Suppl 6: 4-6.
21. Pineyro G, Blier P. Autoregulation of serotonin neurons: role in antidepressant drug action. Pharmacol Rev 1999; 51: 533-91.
22. Mann JJ. Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior. Neuropsychopharmacology 1999; 21 (2 Suppl): 99S-105S.
23. Goodwin GM, De Souza RJ, Green AR. Presynaptic serotonin receptor-mediated response in mice attenuated by antidepressant drugs and electroconvulsive shock. Nature 1985; 317: 531-3.
24. Evrard A, Laporte AM, Chastanet M, Hen R, Hamon M, Adrien J. 5-HT1A and 5-HT1B receptors control the firing of serotoninergic neurons in the dorsal raphe nucleus of the mouse: studies in 5-HT1B knock-out mice. Eur J Neurosci 1999; 11: 3823-31.
25. Sprouse JS, Aghajanian GK. Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists. Synapse 1987; 1: 3-9.
26. Eley TC, Plomin R. Genetic analyses of emotionality. Curr Opin Neurobiol 1997; 7: 279-84.
27. Henderson ND. Interpreting studies that compare high- and low-selected lines on new characters. Behav Genet 1989; 19: 473-502.
28. Porsolt RD, Lenègre A. Behavioural models of depression in Experimental Approaches to Anxiety and Depression. Londres: Wiley 1992: 73-85.
29. Turri MG, Datta SR, DeFries J, Henderson ND, Flint J. QTL analysis identifies multiple behavioral dimensions in ethological tests of anxiety in laboratory mice. Curr Biol 2001; 11: 725-34.
30. Yoshikawa T, Watanabe A, Ishitsuka Y, Nakaya A, Nakatani N. Identification of multiple genetic loci linked to the propensity for "behavioral despair' in mice. Genome Res 2002; 12: 357-66.
31. Overstreet DH. Behavioral characteristics of rat lines selected for differential hypothermic responses to cholinergic or serotonergic agonists. Behav Genet 2002; 32: 335-48.
32. Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology (Berl) 1997; 134: 319-29.
33. Adrien J, Dugovic C, Martin P. Sleep-wakefulness patterns in the helpless rat. Physiol Behav 1991; 49: 257-62.
34. Dugovic C, Maccari S, Weibel L, Turek FW, Van Reeth O. High corticosterone levels in prenatally stressed rats predict persistent paradoxical sleep alterations. J Neurosci 1999; 19: 8656-64.
35. Drevets WC, Raichle ME. Neuroanatomical circuits in depression: implications for treatment mechanisms. Psychopharmacol Bull 1992; 28: 261-74.
36. Naudon L, El Yacoubi M, Vaugeois J-M, Leroux-Nicollet I, Costentin J. A chronic treatment with fluoxetine decreases 5-HT (1A) receptors labeling in mice selected as a genetic model of helplessness. Brain Res 2002; 936: 68-75.
37. Overstreet DH, Daws LC, Schiller GD, Orbach J, Janowsky DS. Cholinergic/serotonergic interactions in hypothermia: implications for rat models of depression. Pharmacol Biochem Behav 1998; 59: 777-85.
38. Maudhuit C, Prevot E, Dangoumau L, Martin P, Hamon M, Adrien J. Antidepressant treatment in helpless rats: effect on the electrophysiological activity of raphe dorsalis serotonergic neurons. Psychopharmacology (Berl) 1997;130: 269-75.
39. Stockmeier CA, Shapiro LA, Dilley GE, Kolli TN, Friedman L, Rajkowska G. Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity. J Neurosci 1998; 18: 7394-401.